Relief Therapeutics Holding SA (OTCMKTS:RLFTF) Stock Falls From The Recent Peak
Shares of Relief Therapeutics Holding SA (OTCMKTS:RLFTF) fell 13% after the biopharmaceutical company said the parent company of its US partner NRx Pharmaceuticals has submitted a revised Investigational New drug module. The submission to the US Food and Drug Administration is for the manufacturing of ZYESAMI(TM) (aviptadil). The module is to be used as part of the FDA’s review process supporting the ZYESAMI(TM) New Drug application. The documentation indicates that…